Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

CHMP recommends marketing authorization for Azarga in open-angle glaucoma

Sep. 30, 2008

Regression of corneal neovascularization with novel antisense oligonucleotide GS-101

Sep. 30, 2008

Independent Data Safety Monitoring supports continuation of Iluvien trial

Sep. 29, 2008

Inspire requests SPA process for Prolacria for dry eye

Sep. 29, 2008

Othera commences phase I/II OT-730 trial in ocular hypertension and glaucoma

Sep. 17, 2008

New compounds for treating glaucoma disclosed in recent Allergan patent

Sep. 17, 2008

Inspire plans clinical testing of new glaucoma compound INS-117548

Sep. 17, 2008

Omeros enrolls patients in phase I/II OMS-302 trial in ophthalmologic surgery

Sep. 16, 2008

Allergan and Asterand sign exclusive license agreement for preclinical compounds for eye diseases

Sep. 15, 2008

SARcode begins phase I trial for LFA-1 product candidate

Sep. 9, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...